Lifeboat Foundation

© Getty Harvard scientists will attempt to replicate the climate-cooling effect of volcanic eruptions with a world-first solar geoengineering experiment set for early 2019.

The Stratospheric Controlled Perturbation Experiment (SCoPEx) will inject calcium carbonate particles high above the earth in an attempt to reflect some of the sun’s rays back into space.

It will likely mark the first time the controversial concept of dimming the sun — more scientifically known as stratospheric aerosol injection (SAI) — will be tested in the real world.

Continue reading “First geoengineering experiment to dim the sun on track for 2019” »

Ophthalmology company Kejako (Geneva, Switzerland) has developed what it calls a noninvasive “Phakorestoration” process, whereby a laser patterns the lens of the eye of a presbyopia patient to restore clear vision just at the level needed for the patient to avoid wearing eyeglasses. This Phakorestoration process is repeated at intervals spanning several years over a patient’s lifetime, prolonging glasses-free vision for as long as 20 years.

By modeling the complete optical parameters of the human eye using COMSOL Multiphysics software, a prescription for a series of noninvasive laser procedures for presbyopia patients can provide glasses-free vision for more than 20 years.

Read more

Indoor living has thrown our circadian clocks out of whack. Ex-NASA space light expert Robert Soler has designed futuristic lights that do a better job mimicking the sun’s full spectrum. His Carlsbad company, Bios Lighting, says their lights are better for human health.

Many people are at the very least iffy about the idea of extending human healthy lifespan through medical biotechnologies that prevent age-related diseases essentially by rejuvenating the body. Even people who accept the possibility that such therapies can be developed are not convinced that developing them is a good idea, and there are only a few arguments that most people use. These arguments can actually be easily adapted to make a case against the medicine that already exists, which the vast majority of people on the planet currently benefit from—and the consensus is virtually universal that people who do not yet benefit from it should be given this opportunity as soon as possible.

The question is: would people who accept these arguments as valid objections to rejuvenation accept them also as valid objections against “normal” medicine? For example, how many present-day people would agree with what these two people from the 1600s are talking about?

A – Did you hear about John’s son?

Countries are rolling out ambitious plans to gain a competitive edge in AI. What principles will ensure that AI is deployed safely and ethically?

Wired

Future Today Institute

To investigate this, the research group launched experiment to try to bind a kaon to a nucleus. To do the experiment, the researchers decided to use a helium-3 target—a nucleus made up of two protons and a single neutron. By knocking out a neutron from the helium-3 target they were able to greatly reduce the energy of the kaon by using the recoil from the ejection and replacing the neutron with a kaon, forming a tightly bound nucleus with two protons and a single kaon.

“What is important about this research,” says Masahiko Iwasaki, the leader of the team, “is that we have shown that mesons can exist in nuclear matter as a real particle—like sugar that is not dissolved in water. This opens up a whole new way to look at and understand nuclei. Understanding such exotic nuclei will give us insights into the origin of the mass of nuclei, as well as to how matter forms in the core of neutron stars. We intend to continue experiments with heavier nuclei to further our understanding of the binding behavior of kaons.”

Both genes and the environment shape a person’s risk of disease, but while genes are frequently cataloged, perturbed, activated, turned off and systematically tested in the lab, environmental exposures are often studied as one-offs. Now Harvard Medical School investigators at Brigham and Women’s Hospital have developed an approach to systematically and simultaneously evaluate the effects of hundreds of environmental factors on the development of neurological diseases.

Through a series of investigations, the team has identified environmental factors that boost neurological inflammation, including an herbicide used in the United States but currently banned in Europe. Details of the team’s approach and findings are published Jan. 17 in Cell.

Get more HM news here.

From Reese Witherspoon to Jeff Bezos, those who are super successful in their chosen domain accept this truth.